Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Piperonylamine

Piperonylamine synthesis

13synthesis methods
-

Yield:2620-50-0 100%

Reaction Conditions:

with lithium aluminium tetrahydride in diethyl ether for 2 h;Reflux;

Steps:

128 Example 128: 3-[(2H-l,3-benzodioxol-5-yl)methyl]-l-[(2,4- difluorophenyl)methyl] - 1 -( 1 -methylpiperidin-4-yl)urea (128)
2H-l,3-benzodioxole-5-carbonitrile (1.73 g, 11.75 mmol) in diethyl ether (15 ml) was added portion wise to a mixture of lithium aluminiumhydride (55.2 mmol hydride, 13.8 mmol, 525 mg) in diethyl ether (15 ml). The mixture was refluxed for 2 hours, then cooled and worked up (H20, 15 % NaOH, 3 x H20) and gave crude benzyl amine (1.77 g, quant.). This amine (1.0 g, 6.6 mmol) and pyridine (1.1 equiv., 17.6 mmol, 1.43 ml) was dissolved in dichloromethane (5.0 ml) and added dropwise to an ice cooled mixture of triphosgene (2.7 mmol, 801 mg,) in dichloromethane (5.0 ml). The mixture was stirred for 1 hour, then partitioned between cold 0.5 M sulfuric acid and dichloromethane. The organic phase was separated, dried and evaporated to give crude 5-(isocyanatomethyl)-2H-l,3-benzodioxole (1.08 g, 92 % yield). (0987) [00644] N-[(2,4-difluorophenyl)methyl]-l-methylpiperidin-4-amine (250 mg, 1.01 mmol) was dissolved in dichloromethane (1 ml) and 5-(isocyanatomethyl)-2H-l,3-benzodioxole (215 mg, 1.21 mmol) in dichloromethane (1 ml) was added in one portion. The mixture was stirred at room temperature for 1 hour and then purified by column chromatography using silicon dioxide gel, eluting with methanol to afford the title compound (275 mg, 66 % yield): NMR (400 MHz, Chloroform-;/) δ 7.21 (q, 1H), 6.87 - 6.73 (m, 2H), 6.73 - 6.59 (m, 3H), 5.92 (s, 2H), 4.57 (t, 1H), 4.40 (s, 2H), 4.29 (d, 2H), 4.26 (m, 1H), 2.88 (d, 2H), 2.27 (s, 3H), 2.07 (m, 2H), 1.75- 1.60 (m, 4H); LC-MS : 418.2 [M+H]+.

References:

ACADIA PHARMACEUTICALS INC.;BURSTEIN, Ethan, S.;OLSSON, Roger;BORGSTRÖM, Björn, Gustav;JANSSON, Karl, Erik;SKÖLD, Niklas, Patrik;VON WACHENFELDT, Henrik;WAHLSTRÖM, Larisa, Yudina WO2019/40107, 2019, A1 Location in patent:Paragraph 00642-00644

FullText

Piperonylamine Related Search: